AFC-HD AMS Life Science Co., Ltd. Cash flow Statement
Figures in Million
Consolidated Cash Flow Results
Aug'25
Aug'24
Aug'23
Aug'22
Aug'21
Aug'20
No of Months
12
12
12
12
12
12
Profit Before Tax
2,200.00
1,910.00
1,545.00
1,235.00
2,157.00
1,004.00
Adjustment
0.00
0.00
0.00
0.00
0.00
0.00
Changes In working Capital
-1,184.00
-812.00
-1,364.00
188.00
71.00
65.00
Cash Flow after changes in Working Capital
0.00
0.00
0.00
0.00
0.00
0.00
Cash Flow from Operating Activities
1,786.00
1,540.00
865.00
1,492.00
2,582.00
1,299.00
Cash Flow from Investing Activities
-3,326.00
-2,761.00
-1,946.00
-1,077.00
-274.00
-458.00
Cash Flow from Financing Activities
666.00
2,232.00
1,881.00
1,159.00
2,185.00
-574.00
Net Cash Inflow / Outflow
-870.00
1,008.00
804.00
1,590.00
4,496.00
268.00
Opening Cash & Cash Equivalents
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
0.00
0.00
0.00
0.00
0.00
Translation adjustment on reserves / op cash balances foreign subsidiaries
0.00
0.00
0.00
0.00
0.00
0.00
Effect of Foreign Exchange Fluctuations
2.00
-2.00
3.00
16.00
3.00
3.00
Closing Cash & Cash Equivalent
0.00
0.00
0.00
0.00
0.00
0.00
Figures in JPY Million
Seasonal companies are compared with the same quarter last year
Seasonal companies are compared with the same quarter last year
Compare Cash Flow Results of AFC-HD AMS Life Science Co., Ltd.
Figures in Million
consolidated Cash Flow Results
Change(JPY)
Change(%)
Profit Before Tax
2200.999
936.687
1,264.00
134.98%
Adjustment
0
0
0.00
0.00%
Changes In working Capital
-1184.342
-906.66
-278.00
-30.63%
Cash Flow after changes in Working Capital
0
0
0.00
0.00%
Cash Flow from Operating Activities
1786.827
-189.093
1,975.00
1044.95%
Cash Flow from Investing Activities
-3326.986
-108.059
-3,218.00
-2978.86%
Cash Flow from Financing Activities
666.749
354.838
312.00
87.90%
Net Cash Inflow / Outflow
-870.67
57.686
-927.00
-1609.33%
Opening Cash & Cash Equivalents
0
0
0.00
0.00%
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0
0
0.00
0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations
0
0
0.00
0.00%
Translation adjustment on reserves / op cash balances foreign subsidiaries
0
0
0.00
0.00%
Effect of Foreign Exchange Fluctuations
2.74
0
2.00
0.00%
Closing Cash & Cash Equivalent
0
0
0.00
0.00%
Cash Flow - Snapshot (Consolidated) - Aug'25
YoY Growth in year ended Aug 2025 is 16.02% vs 77.99% in Aug 2024
Aug'25
Aug'24
Change(%)
Cash Flow from Operating Activities
1,786.83
1,540.09
16.02%






